$2.08
Value –
HAO and T stock compared: price, dividend, valuation and results, from SEC filings.
$2.08
Value –
$22.52
Value $158B
Over the last year, with dividends, HAO moved -99.9% and T -9.3%. Dividend yield: HAO none, T 4.94%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
HAO–
T$158B
Revenue, 12 months
HAO$55M
T$129B
T is 2,350 times HAO
Net income, 12 months
HAO-$9.5M
T$13.1B
Operating margin
HAO-17.6%
T18.3%
35.9 points apart
ROIC
HAO-42.1%
T7.1%
49.2 points apart
P/E
HAO–
T12.1
Dividend yield
HAO0.0%
T4.9%
4.9 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
HAO-99.9%
T-9.3%
| Period | HAOWith dividends | TWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | -99.9%Price -99.9% | -9.3%Price -13.5% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
HAOHaoxi Health Technology Limited - Class A Ord ShareTAT&T
| Price | $2.08 | $22.52 |
|---|---|---|
| Market value | – | $158B |
| Enterprise value (EV) | – | $307B |
| P/E | – | 12.1 |
| P/E, 5-year median | – | 8.8 |
| P/B | – | 1.3 |
| EV/EBIT | – | 13.0 |
| Free cash flow yield | – | 11.3% |
| Revenue, 12 months | $55M | $129B |
|---|---|---|
| Net income, 12 months | -$9.5M | $13.1B |
| Free cash flow, 12 months | – | $17.8B |
| Earnings per share, 12 months | -$386.40 | $1.85 |
| Revenue growth, year on year | 67.1% | 2.7% |
| Revenue growth a year, past | +35.7%over 4 years | -2.6%over 5 years |
| EPS growth a year, past | – | – |
| Gross margin | 1.2% | – |
|---|---|---|
| Operating margin | -17.6% | 18.3% |
| Net margin | -17.4% | 10.2% |
| ROIC | -42.1% | 7.1% |
| ROE | -53.4% | 10.5% |
| Cash | $11M | $10.8B |
|---|---|---|
| Total debt | $1.3M | $178B |
| Net debt / EBITDA | – | 3.4 |
| Interest cover | -184.3× | 3.2× |
| Dividend yield | – | 4.9% |
|---|---|---|
| Dividend per share, 12 months | – | $1.11 |
| Dividend growth a year, past | – | – |
| Buyback yield | – | 2.9% |
| Shareholder yield | – | 7.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Since November 12, 2025, HAO's price moved -99.9% and T's -13.5%. With dividends: HAO -99.9% (-99.9% a year), T -9.3% (-9.3% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Haoxi Health Technology Limited - Class A Ord Share and 4.94% for AT&T. Over the last twelve months they paid – and $1.11 per share.
Over the last twelve months, the net margin was -17.4% for Haoxi Health Technology Limited - Class A Ord Share and 10.2% for AT&T, and the operating margin -17.6% and 18.3%. Revenue was $55M and $129B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.